ROIV

ROIV

USD

Roivant Sciences Ltd. Common Shares

$19.870+0.320 (1.637%)

Real-time Price

Healthcare
Biotechnology
United Kingdom

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$19.550

High

$19.890

Low

$19.315

Volume

9.01M

Company Fundamentals

Market Cap

13.6B

Industry

Biotechnology

Country

United Kingdom

Trading Stats

Avg Volume

7.66M

Exchange

NMS

Currency

USD

52-Week Range

Low $8.73Current $19.870High $20.085

Related News

GlobeNewswire

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.

View more
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Analyst Upgrades

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25

Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.

View more
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

View more
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
GlobeNewswire

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to

View more
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025